Maternal antibody and respiratory syncytial virus infection in infancy
- PMID: 7038043
- DOI: 10.1002/jmv.1890070403
Maternal antibody and respiratory syncytial virus infection in infancy
Abstract
One hundred newborn infants were studied prospectively for 1 year for evidence of infection with respiratory syncytial virus (RSV). The indirect membrane fluorescence technique was used to determine specific antibody in sera. Infection was shown in 29 cases. In 31 infants exposed to an RSV epidemic season, there was no evidence of infection. Maternal antenatal sera were also tested, and wide range of IgG antibody to RSV was found. Mean titre of maternal IgG antibody to RSV was significantly higher (P less than 0.001) in those mothers whose babies remained uninfected than in those whose babies had proved RSV infection before 6 months of age. Babies born to mothers with high levels of IgG antibody to respiratory syncytial virus were protected against infection with this virus during the first months of life when the risk of severe disease was greatest.
Similar articles
-
Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.J Med Virol. 2002 Aug;67(4):616-23. doi: 10.1002/jmv.10148. J Med Virol. 2002. PMID: 12116014
-
Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.J Gen Virol. 1983 Sep;64 (Pt 9):1867-76. doi: 10.1099/0022-1317-64-9-1867. J Gen Virol. 1983. PMID: 6886679
-
[Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies].Arch Fr Pediatr. 1988 Dec;45(10):791-3. Arch Fr Pediatr. 1988. PMID: 3071286 Review. French.
-
Mammary immunity in mothers of infants with respiratory syncytial virus infection.J Med Virol. 1987 Jul;22(3):277-87. doi: 10.1002/jmv.1890220312. J Med Virol. 1987. PMID: 3625176
-
Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.Pediatr Infect Dis J. 1994 May;13(5):449-53. doi: 10.1097/00006454-199405000-00037. Pediatr Infect Dis J. 1994. PMID: 8072835 Review.
Cited by
-
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date.Paediatr Drugs. 2024 Mar;26(2):101-112. doi: 10.1007/s40272-023-00606-6. Epub 2023 Nov 30. Paediatr Drugs. 2024. PMID: 38032456 Free PMC article.
-
The respiratory syncitial virus and its role in acute bronchiolitis.Eur J Pediatr. 1992 Sep;151(9):638-51. doi: 10.1007/BF01957564. Eur J Pediatr. 1992. PMID: 1396923 Review. No abstract available.
-
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US.JAMA Netw Open. 2021 Dec 1;4(12):e2141779. doi: 10.1001/jamanetworkopen.2021.41779. JAMA Netw Open. 2021. PMID: 34913973 Free PMC article.
-
Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.Rev Med Virol. 2014 Jan;24(1):55-70. doi: 10.1002/rmv.1773. Epub 2013 Nov 14. Rev Med Virol. 2014. PMID: 24227634 Free PMC article. Review.
-
Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.Vaccine. 2014 Sep 29;32(43):5761-8. doi: 10.1016/j.vaccine.2014.08.049. Epub 2014 Aug 26. Vaccine. 2014. PMID: 25171847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources